The concept of looking at the effect of liver transplantation on glucose anti‐glycaemic agent (namely insulin) requirements and glycaemic control in patients with pre‐existing diabetes has not been reviewed on a large scale before, making the study concept novel. This evidence concerns the gene INS and diabetes mellitus.